Kapha Bio is developing patented biomaterials that enhance the body's natural defenses against pathogenic bacteria, targeting the root causes of recurrent infections. This technology aims to reduce the incidence of debilitating symptoms and improve the quality of life for billions affected by these infections.
Funding
Funding not disclosed
Founders
Product
Problem
Recurrent infections affect billions, as pathogenic bacteria evade the body's natural defenses. Standard medical treatments often fail to address the underlying causes, leading to high recurrence rates and a diminished quality of life.
Solution
Kapha Bio is developing patented biomaterials designed to enhance the body's natural defenses against pathogenic bacteria. These biomaterials aim to target the root causes of recurrent infections, bolstering the body's ability to combat these pathogens. By strengthening the body's defenses, Kapha Bio seeks to reduce the incidence of debilitating symptoms and improve the overall well-being of individuals affected by recurrent infections. The technology offers a proactive approach to safeguarding human health and liberating people from disruptive cycles of infection.
Target Audience
The primary target audience includes individuals suffering from recurrent infections and healthcare providers seeking innovative solutions to address the root causes of these infections.
Features
- Patented biomaterials designed to enhance the body's natural defenses.
- Technology targets the root causes of recurrent infections.
- Aims to reduce the incidence of debilitating symptoms.
- Seeks to improve the overall well-being of individuals affected by recurrent infections.